Comparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia.

Comparison of the metabolic syndrome risk in valproate-treated patients with epilepsy and the general population in Estonia.

<h4>Background</h4>No study has explored the risk of metabolic syndrome (MS) in patients with epilepsy treated with valproate (VPA) at the population level. The aim of this study was to compare the risk of MS in VPA-treated patients in Estonia to the risk in the general population.<h4...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aleksei Rakitin, Triin Eglit, Sulev Kõks, Margus Lember, Sulev Haldre
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/1ff41c25df85411eadd0a30eacaa791d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares